Abstract
Cancer
remains
a
significant
global
health
challenge
characterized
by
the
uncontrolled
proliferation
of
malignant
cells.
While
conventional
treatments
such
as
chemotherapy
and
radiotherapy
are
effective,
they
often
cause
severe
side
effects,
driving
interest
in
alternative
therapies
derived
from
medicinal
plants.
These
plants
rich
bioactive
compounds,
including
terpenoids,
phenolics,
flavonoids,
which
exhibit
promising
anticancer
properties.
This
review
focuses
on
gas
chromatography–mass
spectrometry
(GC–MS)
for
identifying
characterizing
these
phytochemicals,
highlighting
its
value
natural
product
research
due
to
precise
separation
identification
capabilities.
An
analysis
over
30
studies
identified
key
compounds
with
cytotoxic
effects.
Limonene
(IC
50
:
47–57.34
µg/mL
A549,
HepG2,
CaCo,
PANC‐1
cells),
squalene
26.22
JURKAT),
sesamin
52–57.2
MCF‐7
HCT116
β
‐caryophyllene
19.4–58.2
ME‐180
cells)
have
exhibited
potent
activities.
Despite
advantages,
GC‐MS
realizes
limitations,
difficulty
differentiating
structural
isomers
detecting
low‐abundance
compounds.
Integrating
GC–MS
complementary
analytical
techniques
can
overcome
challenges
enhance
phytochemical
profiling.
Addressing
bioavailability
conducting
clinical
trials
is
essential
translating
findings
into
effective
cancer
therapies.
underscore
therapeutic
potential
phytochemicals
safer
alternatives
treatments.
The
environmental
impact
of
drug
manufacturing
raises
concerns
about
sustainability
in
healthcare.
To
address
this,
exploring
alternative
approaches
to
production
is
crucial.
This
review
focuses
on
seaweed
as
a
sustainable
resource
for
greening
processes.
Seaweed
offers
advantages
such
renewability,
abundance,
and
positive
footprint.
begins
by
providing
an
overview
practices
the
challenges
faced
achieving
sustainability.
It
then
discusses
resource,
including
cultivation
techniques
benefits.
has
various
applications
manufacturing,
extracting
purifying
bioactive
compounds
with
potential
therapeutic
properties.
Seaweed’s
role
developing
green
technologies,
seaweed-based
excipients,
biodegradable
packaging
materials,
source
energy
processes,
highlighted.
economic
implications
incorporating
solutions
are
discussed,
emphasizing
reduced
carbon
footprint
cost-effectiveness.
Regulatory
industrial
perspectives
addressed,
examining
challenges,
opportunities
implementing
manufacturing.
Collaboration
between
academia,
industry,
regulatory
bodies
crucial
successful
integration.
presents
future
directions
opportunities,
emerging
trends
innovations
areas
further
research,
policy
development,
industry
engagement
recommendations.
Incorporating
into
facilitates
reduction
impact,
promotes
efficiency,
contributes
showcases
means
foster
greener
addressing
concerns,
promoting
Organic Chemistry Frontiers,
Год журнала:
2024,
Номер
11(6), С. 1824 - 1842
Опубликована: Янв. 1, 2024
In
this
review,
we
briefly
summarize
the
recent
research
progress
in
enantioselective
higher-order
cycloadditions,
focusing
on
preparation
of
medium-sized
and
multicyclic
chiral
molecules
by
metal-free
catalysis.
Current Issues in Molecular Biology,
Год журнала:
2025,
Номер
47(1), С. 30 - 30
Опубликована: Янв. 6, 2025
Extensive
investigation
has
been
conducted
on
plant-based
resources
for
their
pharmacological
usefulness,
including
various
cancer
types.
The
scope
of
this
review
is
wider
than
several
studies
with
a
particular
focus
breast
cancer,
which
an
international
health
concern
while
studying
sources
flavonoids,
carotenoids,
polyphenols,
saponins,
phenolic
compounds,
terpenoids,
and
glycosides
apart
from
focusing
nursing.
Important
findings
prior
are
synthesized
to
explore
these
compounds'
sources,
mechanisms
action,
complementary
synergistic
effects,
associated
side
effects.
It
was
reviewed
that
the
exposure
certain
doses
catechins,
piperlongumine,
lycopene,
isoflavones
cucurbitacinfor
sufficient
period
can
provide
profound
anticancer
benefits
through
biological
events
such
as
cell
cycle
arrest,
cells
undergoing
apoptosis
disruption
signaling
pathways
including,
but
not
limited
JAK-STAT3,
HER2-integrin,
MAPK.
Besides,
study
also
covers
potential
adverse
effects
phytochemicals.
Regarding
mechanisms,
widest
attention
paid
Complementary
strategies
discussed
indicate
it
would
be
realistic
alter
dosage
delivery
systems
liposomes,
nanoparticles,
nanoemulsions,
films
enhance
efficacy.
Future
research
directions
include
refining
approaches,
further
elucidating
molecular
conducting
clinical
trials
validate
findings.
These
efforts
could
significantly
advance
role
phytocompounds
in
management.
Plants,
Год журнала:
2025,
Номер
14(2), С. 206 - 206
Опубликована: Янв. 13, 2025
Medicinal
plants
are
sources
of
crude
traditional
herbal
medicines
that
utilized
to
reduce
the
risk
of,
treat,
or
manage
diseases
in
most
indigenous
communities.
This
is
due
their
potent
antioxidant
and
anti-inflammatory
effects.
It
estimated
about
80%
population
developing
countries
rely
on
for
healthcare.
signifies
need
medicines,
which
polyherbal
formulations
prepared
by
health
practitioners.
review
examines
preparatory
steps
extract
bioactive
phytoconstituents
post-extraction
processes
increase
potency
extracted
phytoconstituents.
Achieving
this
will
allow
reduced
use
plant
materials
promote
sustainable
limited
resource
medicinal
plants,
especially
our
South
African
context.
Electronic
ethnobotanical
books
online
databases
were
used
find
studies
focus
phytoconstituent
extraction
processing
enhance
Modification
synthesize
daughter
compounds
facilitates
an
enhancement
bioavailability.
Based
data
collected
through
review,
importance
understanding
properties
targeted
essential
selecting
required
method.
determines
quality
yield
Biomedicines,
Год журнала:
2025,
Номер
13(2), С. 454 - 454
Опубликована: Фев. 12, 2025
Conditions
like
diabetes
mellitus
(DM),
cancer,
infections,
inflammation,
cardiovascular
diseases
(CVDs),
and
gastrointestinal
(GI)
disorders
continue
to
have
a
major
global
impact
on
mortality
morbidity.
Medicinal
plants
been
used
since
ancient
times
in
ethnomedicine
(e.g.,
Ayurveda,
Unani,
Traditional
Chinese
Medicine,
European
Medicine)
for
the
treatment
of
wide
range
disorders.
Plants
are
rich
source
diverse
phytoconstituents
with
antidiabetic,
anticancer,
antimicrobial,
antihypertensive,
antioxidant,
antihyperlipidemic,
cardioprotective,
immunomodulatory,
and/or
anti-inflammatory
activities.
This
review
focuses
35
most
commonly
reported
these
disorders,
particular
emphasis
their
traditional
uses,
phytoconstituent
contents,
pharmacological
properties,
modes
action.
Active
phytomolecules
therapeutic
potential
include
cucurbitane
triterpenoids,
diosgenin,
limonoids
(azadiradione
gedunin),
which
exhibit
antidiabetic
triterpenoids
specifically
activating
Glucose
Transporter
Type
4
(GLUT4)
translocation.
Capsaicin
curcumin
demonstrate
anticancer
activity
by
deactivating
NF-κB
arresting
cell
cycle
G2
phase.
Antimicrobial
activities
observed
piperine,
reserpine,
berberine,
dictamnine,
chelerythrine,
allitridin,
latter
two
triggering
bacterial
lysis.
Quercetin,
catechin,
genistein
suppressing
CD8+
cytotoxic
T
function.
Ginsenoside
Rg1
ginsenoside
Rg3
treating
diseases,
PPARα
promoter,
PI3K/Akt
pathway.
In
contrast,
ternatin,
tannins,
quercitrin
regulating
arachidonic
acid
metabolism
cyclooxygenase
(COX)
lipoxygenase
activity.
Further
studies
warranted
fully
investigate
clinical
benefits
phytoconstituents,
as
well
elucidate
underlying
molecular
mechanisms
BMC Complementary Medicine and Therapies,
Год журнала:
2025,
Номер
25(1)
Опубликована: Фев. 14, 2025
The
World
Health
Organization
encourages
governments
to
develop
legal
frameworks
for
the
regulation
of
traditional
medicines
ensure
safety,
quality,
and
efficacy.
There
is
inadequate
published
research
on
medicine
legislative
tools
Good
manufacturing
practices
compliance
by
manufacturers
in
many
countries
Sub-Saharan
Africa.
study
assessed
regulatory
status
challenges
Malawi
Nigeria.
A
descriptive
cross-sectional
was
done
using
a
structured
questionnaire
checklist
requirements
collect
data
from
officers,
facilities,
herbal
medicinal
products.
Twenty-three
officers
Medicines
Regulatory
Authorities
Ministries
Nigeria
were
interviewed.
Thirty-one
small-scale
manufacturers,
sixty-six
products
Malawi,
twenty-eight
Nigeria,
that
used
people
living
with
HIV
AIDS,
evaluated.
Pharmacy
Authority
scored
7.7%
while
National
Agency
Food
Drug
Administration
Control
77.0%
13-item
requirements.
Ministry
Health,
28.6%
71.4%
7-item
Both
have
no
regulations
practice,
has
not
been
integrated
into
healthcare
system.
Most
Malawian
showed
poor
compliance,
deficiencies
observed
personnel
hygiene
(58.6%),
cleaning
production
equipment
(69.0%),
storage
rooms
(72.4%),
documentation
standard
operating
procedures
premises
(93.1%).
Labelling
non-compliance
respectively,
list
active
ingredient
names
(45.5%
vs.
93.0%,
p
<
0.001),
quantities
ingredients
(12.1%
53.6%,
side
effects
(9.1%
57.1%,
conditions
(15.2%
67.9%,
0.001).
lacks
strong
framework
medicines,
current
Manufacturing
Practices
standards
labelling,
posing
serious
public
health
risks.
Urgent
action
needed
establish
comprehensive
regulations,
including
guidelines
registering
AIDS.
While
more
developed
framework,
enforcement
remains
challenge.
Strengthening
inspections
ensuring
adherence
safety
quality
critical
safeguarding
building
consumer
confidence
both
countries'
industries.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(13), С. 6937 - 6937
Опубликована: Июнь 25, 2024
Cancer
remains
a
significant
global
health
challenge,
with
millions
of
deaths
attributed
to
it
annually.
Radiotherapy,
cornerstone
in
cancer
treatment,
aims
destroy
cells
while
minimizing
harm
healthy
tissues.
However,
the
harmful
effects
irradiation
on
normal
present
formidable
obstacle.
To
mitigate
these
effects,
researchers
have
explored
using
radioprotectors
and
mitigators,
including
natural
compounds
derived
from
secondary
plant
metabolites.
This
review
outlines
diverse
classes
compounds,
elucidating
their
roles
as
protectants
cells.
Furthermore,
highlights
potential
radioprotective
agents
capable
enhancing
body's
resilience
radiation
therapy.
By
integrating
into
treatment
regimens,
clinicians
may
improve
therapeutic
outcomes
adverse
Ongoing
research
this
area
holds
promise
for
developing
complementary
strategies
optimize
radiotherapy
efficacy
enhance
patient
quality
life.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Май 30, 2024
Introduction
In
recent
years,
diverse
initiatives
have
been
carried
out
to
control
the
COVID-19
pandemic,
ranging
from
measures
restricting
social
activities
analyzing
drugs
and
vaccines.
Studies
on
herbal
medicines
are
also
increasingly
conducted
in
various
countries
as
an
adjuvant
therapy
or
supplement.
Therefore,
this
systematic
review
aimed
investigate
efficacy
of
analyzed
through
clinical
trials
with
randomized
controlled
trial
method.
The
outcomes
Length
Stay
(LOS),
Negative
Conversion
Time
(NCT),
Rate
(NCR)
were
main
focus.
Methods
An
extensive
literature
spanning
2019
2023
was
using
well-known
databases
including
PubMed,
Scopus,
Cochrane.
search
included
relevant
keywords
such
“randomized
trial,”
“COVID-19,”
“herbal
medicine.”
Results
A
total
8
articles
part
inclusion
criteria
LOS,
NCT,
NCR.
terms
LOS
outcomes,
all
types
showed
significant
results,
Persian
Medicine
Herbal
(PM
Herbal),
Barley
Water
(PBW),
Jingyin
Granules
(JY
granules),
Reduning
Injection,
Phyllanthus
emblica
(Amla).
However,
only
JY
granules
results
NCR
outcome,
while
Injection
reducing
NCT.
Conclusion
These
findings
enrich
our
understanding
potential
benefits
influencing
NCT
parameters
patients.
worked
treat
antiviral,
anti-inflammatory,
immunomodulatory
mechanisms.